Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
22.33
-0.31 (-1.37%)
At close: Jun 18, 2026, 4:00 PM EDT
22.33
0.00 (0.01%)
After-hours: Jun 18, 2026, 4:24 PM EDT
Pacira BioSciences Employees
As of December 31, 2025, Pacira BioSciences had 829 total employees, including 825 full-time and 4 part-time employees. The number of employees increased by 39 or 4.94% compared to the previous year.
Employees
829
Change (1Y)
39
Growth (1Y)
4.94%
Revenue / Employee
$886,446
Profits / Employee
$6,198
Market Cap
878.64M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 829 | 39 | 4.94% | 825 | 4 |
| Dec 31, 2024 | 790 | 78 | 10.96% | 788 | 2 |
| Dec 31, 2023 | 712 | -3 | -0.42% | 711 | 1 |
| Dec 31, 2022 | 715 | 18 | 2.58% | 715 | 0 |
| Dec 31, 2021 | 697 | 73 | 11.70% | 697 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evotec SE | 4,526 |
| Phibro Animal Health | 2,475 |
| Amphastar Pharmaceuticals | 1,976 |
| Alvotech | 1,279 |
| Cronos Group | 610 |
| Xeris Biopharma Holdings | 435 |
| Collegium Pharmaceutical | 423 |
| Esperion Therapeutics | 294 |
PCRX News
- 4 days ago - 20 growth stocks priced as value stocks - Market Watch
- 9 days ago - Pacira BioSciences Announces Stockholders Have Elected All Three of the Company's Director Nominees at Annual Meeting - PRNewsWire
- 11 days ago - Pacira BioSciences Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 14 days ago - Pacira BioSciences Reminds Stockholders to Vote the BLUE Proxy Card "FOR" the Election of the Company's Highly Qualified Nominees Ahead of its Annual Meeting - PRNewsWire
- 15 days ago - Pacira BioSciences Proxy statement: Proxy filing - Filings
- 16 days ago - Pacira BioSciences Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 17 days ago - Pacira BioSciences Highlights Leading Independent Proxy Advisory Firm ISS' Recommendation to Vote "FOR" All of Pacira's Director Nominees - PRNewsWire
- 18 days ago - PharmaCorp Rx Inc. Announces First Quarter 2026 Financial Results - GlobeNewsWire